CureVac N.V. (FRA:5CV)
4.350
-0.114 (-2.55%)
Dec 2, 2025, 12:11 PM CET
CureVac Revenue
CureVac had revenue of 54.13M EUR in the quarter ending September 30, 2025, a decrease of -89.04%. This brings the company's revenue in the last twelve months to 70.74M, down -86.98% year-over-year. In the year 2024, CureVac had annual revenue of 535.18M with 895.54% growth.
Revenue (ttm)
70.74M
Revenue Growth
-86.98%
P/S Ratio
14.24
Revenue / Employee
n/a
Employees
983
Market Cap
1.01B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 535.18M | 481.42M | 895.54% |
| Dec 31, 2023 | 53.76M | -13.66M | -20.26% |
| Dec 31, 2022 | 67.42M | -35.57M | -34.54% |
| Dec 31, 2021 | 102.99M | 54.12M | 110.74% |
| Dec 31, 2020 | 48.87M | 31.46M | 180.61% |
| Dec 31, 2019 | 17.42M | 4.55M | 35.31% |
| Dec 31, 2018 | 12.87M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.87B |
| Siemens Healthineers AG | 23.38B |
| Fresenius SE & Co. KGaA | 22.45B |
| Merck KGaA | 21.27B |
| Fresenius Medical Care AG | 19.64B |
| Sartorius Aktiengesellschaft | 3.52B |
| Redcare Pharmacy NV | 2.82B |
| Fielmann Group AG | 2.42B |
CureVac News
- 4 days ago - CureVac N.V. (CVAC) Shareholder/Analyst Call Prepared Remarks Transcript - Seeking Alpha
- 5 days ago - BioNTech (BNTX) Moves Forward with CureVac Acquisition - GuruFocus
- 6 days ago - BioNTech (BNTX) Advances with Exchange Offer for CureVac Shares - GuruFocus
- 6 days ago - BioNTech’s exchange offer for German mRNA vaccine peer CureVac set to expire Dec. 3 - Seeking Alpha
- 6 days ago - CureVac Announces Voting Results of Extraordinary General Meeting - Accesswire
- 6 days ago - CureVac Reveals Key Voting Outcomes from Extraordinary Shareholder Meeting - Wallstreet:Online
- 6 days ago - EQS-News: CureVac Announces Voting Results of Extraordinary General Meeting • news - Onvista
- 7 days ago - Company News for Nov 25, 2025 - Nasdaq